Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Understanding Mitral Valve Disease: Causes, Symptoms, and Treatment

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by

Mitral valve disease encompasses a spectrum of conditions affecting the mitral valve, a vital heart valve between the left atrium and left ventricle. The mitral valve ensures the unidirectional blood flow through the heart to the body. Dysfunction of this valve can lead to significant morbidity, including heart failure, arrhythmias, and an increased risk of stroke.Β 

This article discusses mitral valve anatomy and function and the various types of mitral valve disease, diagnosis, and treatment.

[signup]

What is Mitral Valve Disease?

The mitral valve is one of the four main heart valves essential to cardiac function. It is located between the heart's left atrium and left ventricle.Β 

Source: https://my.clevelandclinic.org/health/body/23244-mitral-valve

The mitral valve consists of 2 flaps (known as leaflets), chordae tendineae, and papillary muscles. The leaflets are thin, flexible flaps that open and close to regulate blood flow. The chordae tendineae are string-like structures that anchor the leaflets to the papillary muscles, which contract to prevent leaflet prolapse.

[37]

The mitral valve ensures unidirectional blood flow from the left atrium to the left ventricle.

  • During diastole (when the heart relaxes after a contraction), the valve opens, allowing oxygenated blood from the lungs to fill the left ventricle.
  • During systole (when the heart contracts), the valve closes to prevent blood from back flowing into the left atrium as the left ventricle contracts to pump blood into the body.

Types of Mitral Valve Disease

There are three primary types of mitral valve disease: mitral valve stenosis, prolapse, and regurgitation:

  1. Mitral regurgitation (MR) is the most common type, with a prevalence of about 1 in 10 people in the US.Β  It occurs when the valve between the left heart chambers does not fully close.Β  Consequently, blood leaks backward into the left atrium.Β 

This can lead to an increased volume load on the left atrium and ventricle, resulting in dilation and enlargement of these chambers. Chronic MR can result in left ventricular dysfunction, heart failure, and atrial fibrillation due to atrial enlargement.

  1. Mitral valve stenosis involves narrowing the mitral valve opening, often due to rheumatic fever. It affects about 1 in 100,000 people in the US and is characterized by restricted blood flow from the left atrium to the left ventricle, which increases pressure in the left atrium and pulmonary circulation.Β 
  2. Mitral valve prolapse occurs when the valve's flaps (leaflets) become floppy, stretchy, and bulge (prolapse) into the left atrium during heart contractions. It is estimated to affect 1 in 33 people in the US. Prolapse can lead to mitral regurgitation, where blood leaks back into the left atrium, decreasing the heart's efficiency.

Causes and Risk Factors

Common causes of MVD include:

  • Rheumatic Fever: Rheumatic fever, caused by streptococcal infections, is a significant cause of mitral valve stenosis. It causes inflammation that can scar and fuse the valve leaflets, leading to stenosis.
  • Degenerative Valve Disease: As people age, changes like those seen in mitral valve prolapse (MVP) occur due to "wear and tear" (degeneration). This condition makes the valve leaflets and chordae tendineae longer, causing them to prolapse and leak.
  • Ischemic Heart Disease: A heart attack can damage the papillary muscles or the valve annulus, leading to mitral regurgitation.
  • Congenital Defects: Some people are born with mitral valve defects, which can cause it to either narrow (stenosis) or leak (regurgitation) from birth.
  • Infective Endocarditis: An infection of the valve leaflets can cause damage and deformities, leading to sudden (acute) mitral regurgitation.

Risk Factors

Several risk factors predispose individuals to MVD:

  • Age: The risk of degenerative mitral valve disease increases with age.
  • Gender: Mitral valve prolapse is more commonly diagnosed in women, whereas aortic stenosis is more common in men.
  • History of Rheumatic Fever: Previous episodes increase the risk of developing mitral valve stenosis.
  • Connective Tissue Disorders: Marfan syndrome and Ehlers-Danlos syndrome are associated with mitral valve prolapse.
  • Chronic Kidney Disease (CKD): Those with chronic kidney disease are at higher risk due to associated metabolic changes and hypertension.
  • Hypertension: Chronically high blood pressure can lead to left ventricular hypertrophy and mitral regurgitation.
  • Radiation treatment: Chest radiation treatment for cancer may cause thickening and stenosis of the valves.

Symptoms of Mitral Valve Disease (MVD)

Symptoms vary by type of MVD:Β Β 

Diagnosis of Mitral Valve Disease

Diagnosing mitral valve disease involves several key steps and modalities to ensure accurate assessment and treatment. These include:

  1. Physical Examination: Doctors listen to the heart using a stethoscope to detect abnormal sounds, such as murmurs, that can indicate issues with the mitral valve.Β 
  2. Echocardiography: This test uses ultrasound waves to capture detailed images of the heart, allowing doctors to see the mitral valve's structure and movement. It helps diagnose conditions like mitral stenosis and regurgitation by showing how well the valve opens and closes and measuring blood flow through the heart.
  3. Electrocardiogram (ECG): An ECG records the heart's electrical activity and can help diagnose mitral valve disease. It detects irregular heart rhythms and other electrical abnormalities that may be caused by or contribute to mitral valve problems. An ECG can also show signs of an enlarged heart or previous heart attacks, which can affect the mitral valve.
  4. Chest X-Ray: Chest X-rays provide images of the heart and lungs, helping doctors see if the heart is enlarged, which can occur with mitral valve disease. X-rays also show fluid in the lungs, a sign of heart failure often associated with severe mitral valve disease.

Advanced diagnostic tests can help better assess mitral valve disease and treatment strategies. These include:Β 

  • Transesophageal Echocardiography (TEE): Unlike a regular (transthoracic) echocardiogram, where the ultrasound probe is placed on the chest, TEE involves guiding a probe down the esophagus, which lies close to the heart. This provides more precise and detailed images of the mitral valve and its function.
  • Cardiac MRI: MRI uses magnetic fields to create detailed images of the heart's structures and blood flow. It offers excellent visualization of the heart tissues and valves, allowing assessment of the extent of valve damage and the impact on heart function.Β 
  • Cardiac Catheterization: Cardiac catheterization helps evaluate the severity of mitral valve disease. A thin tube (a catheter) is inserted into a blood vessel and guided to the heart. It allows for the measurement of pressures within the heart chambers and the assessment of oxygen levels. A dye may be injected to allow X-ray visualization of blood flow through the heart's vessels and valves. This helps in planning appropriate treatments, such as valve repair versus replacement.

Treatment and Management of Mitral Valve Disease

Effective management of mitral valve disease requires a combination of medical, surgical, and lifestyle approaches to optimize heart function and patient quality of life.

Medications

Commonly used medicines to alleviate MVD symptoms include:

  • Diuretics: Reduce fluid buildup in the lungs and body.
  • Beta-blockers: Slow down the heart rate and reduce blood pressure.
  • ACE inhibitors: Decrease blood pressure and strain on the heart.
  • Anticoagulants: Prevent blood clots, especially in patients with atrial fibrillation.

Surgical Interventions

Mitral Valve Repair: Usually performed when the valve has minimal damage and is amenable to repair.Β  Common procedures include:

  • Annuloplasty: Tightening or reinforcing the ring around the valve (annulus) to improve its function.
  • Leaflet repair: Reshaping or removing part of the valve leaflets to ensure proper closure.
  • Chordae repair: Shortening or replacing the chordae tendineae to prevent leaflet prolapse.

Mitral Valve Replacement: Necessary when the valve is too damaged to repair. Common types of replacement (prosthetic) valves are:

  • Mechanical valves: Made of durable materials, they require lifelong anticoagulation therapy.Β 
  • Biological valves: Made from animal tissue, they are less durable but do not require long-term anticoagulation therapy.

Minimally Invasive Procedures

  • Transcatheter Mitral Valve Repair (TMVR): A catheter-based technique to repair the valve without open-heart surgery.
  • Mitral Clip: A device inserted via catheter clips the valve leaflets together, reducing regurgitation.

Non-Surgical Treatments: Lifestyle Changes

Regular check-ups are essential for monitoring valve function and heart health and should include imaging (e.g., echocardiogram, ECG) to assess valve status.

Prognosis and Complications

The prognosis of mitral valve disease varies based on several factors, including disease severity, patient health, and timely treatment.Β 

Prognosis Considerations

  • Severity of Disease: Mild cases may not significantly affect life expectancy or quality of life, while severe cases can lead to serious complications.
  • Age and overall health status: Younger patients and those in good overall health tend to have better outcomes.
  • Timely Treatment: Early diagnosis and treatment significantly improve prognosis.Β 

Potential Complications

  • Atrial Fibrillation: Irregular heart rhythms can lead to blood clots, stroke, and other heart-related complications.
  • Heart failure: The heart may become too weak to pump blood effectively, leading to fatigue, shortness of breath, and fluid buildup.
  • Pulmonary hypertension: Backflow of blood increases blood pressure in the lungs' arteries and strains the right side of the heart.
  • Prophylactic antibiotic therapy:Β  People with mitral valve disease or a prosthetic valve who do not receive prophylactic antibiotic therapy before a dental procedure or oral surgery are at high risk for developing endocarditis.

Managing Complications

Managing potential complications through early detection and ongoing care is essential to improving outcomes.

Early DetectionΒ 

  • Regular Check-Ups: Routine examinations can catch complications early.
  • Screening Tests: Echocardiograms and ECGs can detect changes in heart function and structure early, leading to timely interventions.
  • Medication: Prescribing appropriate medications to manage symptoms and prevent progression.

Ongoing Care

  • Patient Education: Educating patients about their condition, medication adherence, and lifestyle changes is crucial for long-term management.
  • Lifestyle Modifications: Encouraging a heart-healthy diet, regular exercise, and smoking cessation to improve overall heart health.
  • Follow-Up Appointments: Regular follow-ups with a cardiologist to monitor heart function and adjust treatments as needed.

Recent Advances in Mitral Valve Disease Research and Treatment

Recent advances in mitral valve research and treatment have significantly improved patient outcomes.

Clinical Trials

Numerous clinical trials are exploring innovative approaches to mitral valve disease. For instance, the MITRAL II clinical trial is being conducted to examine the safety of various prosthetic valves in patients with severe mitral annular calcification.Β Β 

Another clinical trial, the ALIVE trial, is being performed to assess the efficacy of different diagnostic modalities for atrial fibrosis (a condition where connective tissue forms in the heart muscle) in patients with mitral regurgitation. A list of ongoing clinical trials can be found on the clinicaltrials.gov website.

Technological Advancements

Robotic-assisted mitral valve surgery represents a significant technological leap. This minimally invasive approach allows for greater precision, smaller incisions, and reduced blood loss, leading to faster recovery and fewer complications.Β 

Genetic and Molecular Research

Research into mitral valve disease's genetic and molecular basis is also advancing. Identifying genetic mutations linked to mitral valve prolapse (MVP) can lead to targeted therapies and personalized medicine approaches.Β 

Additionally, understanding the molecular pathways involved in valve degeneration can pave the way for novel pharmacological treatments to slow or reverse disease progression.

[signup]

Key Takeaways

  • Mitral valve diseases include mitral valve regurgitation, prolapse, and stenosis, with mitral valve regurgitation being the most common type.
  • Common causes of mitral valve disease include rheumatic fever, degenerative changes, endocarditis, and congenital abnormalities.
  • Symptoms vary by type of mitral valve disease. Common symptoms include fatigue, shortness of breath, chest pain, and symptoms of heart failure.
  • Early diagnosis and intervention are critical. Echocardiograms and cardiac MRI are often used to evaluate heart valves precisely.
  • Treatments include medications to alleviate symptoms and surgical intervention to repair or replace the diseased valve.
  • Comprehensive care and routine follow-ups with a cardiologist improve outcomes for those with mitral valve disease.
  • Recent advances in mitral valve research and treatment have significantly improved patient outcomes.Β 

Mitral valve disease encompasses a spectrum of conditions affecting the mitral valve, a vital heart valve between the left atrium and left ventricle. The mitral valve ensures the unidirectional blood flow through the heart to the body. Dysfunction of this valve can lead to significant health issues, including heart failure, arrhythmias, and an increased risk of stroke.Β 

This article discusses mitral valve anatomy and function and the various types of mitral valve disease, diagnosis, and management options.

[signup]

What is Mitral Valve Disease?

The mitral valve is one of the four main heart valves essential to cardiac function. It is located between the heart's left atrium and left ventricle.Β 

Source: https://my.clevelandclinic.org/health/body/23244-mitral-valve

The mitral valve consists of 2 flaps (known as leaflets), chordae tendineae, and papillary muscles. The leaflets are thin, flexible flaps that open and close to regulate blood flow. The chordae tendineae are string-like structures that anchor the leaflets to the papillary muscles, which contract to prevent leaflet prolapse.

[37]

The mitral valve ensures unidirectional blood flow from the left atrium to the left ventricle.

  • During diastole (when the heart relaxes after a contraction), the valve opens, allowing oxygenated blood from the lungs to fill the left ventricle.
  • During systole (when the heart contracts), the valve closes to prevent blood from back flowing into the left atrium as the left ventricle contracts to pump blood into the body.

Types of Mitral Valve Disease

There are three primary types of mitral valve disease: mitral valve stenosis, prolapse, and regurgitation:

  1. Mitral regurgitation (MR) is the most common type, with a prevalence of about 1 in 10 people in the US.Β  It occurs when the valve between the left heart chambers does not fully close.Β  Consequently, blood leaks backward into the left atrium.Β 

This can lead to an increased volume load on the left atrium and ventricle, resulting in dilation and enlargement of these chambers. Chronic MR can result in left ventricular dysfunction, heart failure, and atrial fibrillation due to atrial enlargement.

  1. Mitral valve stenosis involves narrowing the mitral valve opening, often due to rheumatic fever. It affects about 1 in 100,000 people in the US and is characterized by restricted blood flow from the left atrium to the left ventricle, which increases pressure in the left atrium and pulmonary circulation.Β 
  2. Mitral valve prolapse occurs when the valve's flaps (leaflets) become floppy, stretchy, and bulge (prolapse) into the left atrium during heart contractions. It is estimated to affect 1 in 33 people in the US. Prolapse can lead to mitral regurgitation, where blood leaks back into the left atrium, decreasing the heart's efficiency.

Causes and Risk Factors

Common causes of MVD include:

  • Rheumatic Fever: Rheumatic fever, caused by streptococcal infections, is a significant cause of mitral valve stenosis. It causes inflammation that can scar and fuse the valve leaflets, leading to stenosis.
  • Degenerative Valve Disease: As people age, changes like those seen in mitral valve prolapse (MVP) occur due to "wear and tear" (degeneration). This condition makes the valve leaflets and chordae tendineae longer, causing them to prolapse and leak.
  • Ischemic Heart Disease: A heart attack can damage the papillary muscles or the valve annulus, leading to mitral regurgitation.
  • Congenital Defects: Some people are born with mitral valve defects, which can cause it to either narrow (stenosis) or leak (regurgitation) from birth.
  • Infective Endocarditis: An infection of the valve leaflets can cause damage and deformities, leading to sudden (acute) mitral regurgitation.

Risk Factors

Several risk factors predispose individuals to MVD:

  • Age: The risk of degenerative mitral valve disease increases with age.
  • Gender: Mitral valve prolapse is more commonly diagnosed in women, whereas aortic stenosis is more common in men.
  • History of Rheumatic Fever: Previous episodes increase the risk of developing mitral valve stenosis.
  • Connective Tissue Disorders: Marfan syndrome and Ehlers-Danlos syndrome are associated with mitral valve prolapse.
  • Chronic Kidney Disease (CKD): Those with chronic kidney disease are at higher risk due to associated metabolic changes and hypertension.
  • Hypertension: Chronically high blood pressure can lead to left ventricular hypertrophy and mitral regurgitation.
  • Radiation treatment: Chest radiation treatment for cancer may cause thickening and stenosis of the valves.

Symptoms of Mitral Valve Disease (MVD)

Symptoms vary by type of MVD:Β Β 

Diagnosis of Mitral Valve Disease

Diagnosing mitral valve disease involves several key steps and modalities to ensure accurate assessment and management. These include:

  1. Physical Examination: Doctors listen to the heart using a stethoscope to detect abnormal sounds, such as murmurs, that can indicate issues with the mitral valve.Β 
  2. Echocardiography: This test uses ultrasound waves to capture detailed images of the heart, allowing doctors to see the mitral valve's structure and movement. It helps identify conditions like mitral stenosis and regurgitation by showing how well the valve opens and closes and measuring blood flow through the heart.
  3. Electrocardiogram (ECG): An ECG records the heart's electrical activity and can help identify mitral valve disease. It detects irregular heart rhythms and other electrical abnormalities that may be caused by or contribute to mitral valve problems. An ECG can also show signs of an enlarged heart or previous heart attacks, which can affect the mitral valve.
  4. Chest X-Ray: Chest X-rays provide images of the heart and lungs, helping doctors see if the heart is enlarged, which can occur with mitral valve disease. X-rays also show fluid in the lungs, a sign of heart failure often associated with severe mitral valve disease.

Advanced diagnostic tests can help better assess mitral valve disease and management strategies. These include:Β 

  • Transesophageal Echocardiography (TEE): Unlike a regular (transthoracic) echocardiogram, where the ultrasound probe is placed on the chest, TEE involves guiding a probe down the esophagus, which lies close to the heart. This provides more precise and detailed images of the mitral valve and its function.
  • Cardiac MRI: MRI uses magnetic fields to create detailed images of the heart's structures and blood flow. It offers excellent visualization of the heart tissues and valves, allowing assessment of the extent of valve damage and the impact on heart function.Β 
  • Cardiac Catheterization: Cardiac catheterization helps evaluate the severity of mitral valve disease. A thin tube (a catheter) is inserted into a blood vessel and guided to the heart. It allows for the measurement of pressures within the heart chambers and the assessment of oxygen levels. A dye may be injected to allow X-ray visualization of blood flow through the heart's vessels and valves. This helps in planning appropriate management, such as valve repair versus replacement.

Management of Mitral Valve Disease

Effective management of mitral valve disease requires a combination of medical, surgical, and lifestyle approaches to optimize heart function and patient quality of life.

Medications

Commonly used medicines to help manage MVD symptoms include:

  • Diuretics: May help reduce fluid buildup in the lungs and body.
  • Beta-blockers: Can help slow down the heart rate and reduce blood pressure.
  • ACE inhibitors: May help decrease blood pressure and strain on the heart.
  • Anticoagulants: Can help prevent blood clots, especially in patients with atrial fibrillation.

Surgical Interventions

Mitral Valve Repair: Usually performed when the valve has minimal damage and is amenable to repair.Β  Common procedures include:

  • Annuloplasty: Tightening or reinforcing the ring around the valve (annulus) to improve its function.
  • Leaflet repair: Reshaping or removing part of the valve leaflets to ensure proper closure.
  • Chordae repair: Shortening or replacing the chordae tendineae to prevent leaflet prolapse.

Mitral Valve Replacement: Necessary when the valve is too damaged to repair. Common types of replacement (prosthetic) valves are:

  • Mechanical valves: Made of durable materials, they require lifelong anticoagulation therapy.Β 
  • Biological valves: Made from animal tissue, they are less durable but do not require long-term anticoagulation therapy.

Minimally Invasive Procedures

  • Transcatheter Mitral Valve Repair (TMVR): A catheter-based technique to repair the valve without open-heart surgery.
  • Mitral Clip: A device inserted via catheter clips the valve leaflets together, reducing regurgitation.

Non-Surgical Treatments: Lifestyle Changes

Regular check-ups are essential for monitoring valve function and heart health and should include imaging (e.g., echocardiogram, ECG) to assess valve status.

Prognosis and Complications

The prognosis of mitral valve disease varies based on several factors, including disease severity, patient health, and timely management.Β 

Prognosis Considerations

  • Severity of Disease: Mild cases may not significantly affect life expectancy or quality of life, while severe cases can lead to serious complications.
  • Age and overall health status: Younger patients and those in good overall health tend to have better outcomes.
  • Timely Management: Early diagnosis and management significantly improve prognosis.Β 

Potential Complications

  • Atrial Fibrillation: Irregular heart rhythms can lead to blood clots, stroke, and other heart-related complications.
  • Heart failure: The heart may become too weak to pump blood effectively, leading to fatigue, shortness of breath, and fluid buildup.
  • Pulmonary hypertension: Backflow of blood increases blood pressure in the lungs' arteries and strains the right side of the heart.
  • Prophylactic antibiotic therapy:Β  People with mitral valve disease or a prosthetic valve who do not receive prophylactic antibiotic therapy before a dental procedure or oral surgery are at high risk for developing endocarditis.

Managing Complications

Managing potential complications through early detection and ongoing care is essential to improving outcomes.

Early DetectionΒ 

  • Regular Check-Ups: Routine examinations can catch complications early.
  • Screening Tests: Echocardiograms and ECGs can detect changes in heart function and structure early, leading to timely interventions.
  • Medication: Prescribing appropriate medications to manage symptoms and prevent progression.

Ongoing Care

  • Patient Education: Educating patients about their condition, medication adherence, and lifestyle changes is crucial for long-term management.
  • Lifestyle Modifications: Encouraging a heart-healthy diet, regular exercise, and smoking cessation to improve overall heart health.
  • Follow-Up Appointments: Regular follow-ups with a cardiologist to monitor heart function and adjust treatments as needed.

Recent Advances in Mitral Valve Disease Research and Management

Recent advances in mitral valve research and management have significantly improved patient outcomes.

Clinical Trials

Numerous clinical trials are exploring innovative approaches to mitral valve disease. For instance, the MITRAL II clinical trial is being conducted to examine the safety of various prosthetic valves in patients with severe mitral annular calcification.Β Β 

Another clinical trial, the ALIVE trial, is being performed to assess the efficacy of different diagnostic modalities for atrial fibrosis (a condition where connective tissue forms in the heart muscle) in patients with mitral regurgitation. A list of ongoing clinical trials can be found on the clinicaltrials.gov website.

Technological Advancements

Robotic-assisted mitral valve surgery represents a significant technological leap. This minimally invasive approach allows for greater precision, smaller incisions, and reduced blood loss, leading to faster recovery and fewer complications.Β 

Genetic and Molecular Research

Research into mitral valve disease's genetic and molecular basis is also advancing. Identifying genetic mutations linked to mitral valve prolapse (MVP) can lead to targeted therapies and personalized medicine approaches.Β 

Additionally, understanding the molecular pathways involved in valve degeneration can pave the way for novel pharmacological treatments to slow or reverse disease progression.

[signup]

Key Takeaways

  • Mitral valve diseases include mitral valve regurgitation, prolapse, and stenosis, with mitral valve regurgitation being the most common type.
  • Common causes of mitral valve disease include rheumatic fever, degenerative changes, endocarditis, and congenital abnormalities.
  • Symptoms vary by type of mitral valve disease. Common symptoms include fatigue, shortness of breath, chest pain, and symptoms of heart failure.
  • Early diagnosis and intervention are critical. Echocardiograms and cardiac MRI are often used to evaluate heart valves precisely.
  • Management includes medications to help manage symptoms and surgical intervention to repair or replace the diseased valve.
  • Comprehensive care and routine follow-ups with a cardiologist improve outcomes for those with mitral valve disease.
  • Recent advances in mitral valve research and management have significantly improved patient outcomes.Β 
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No lab tests!
  1. American Heart Association. (n.d.). Medications for Heart Valve Symptoms. Www.heart.org. Retrieved June 15, 2024, from https://www.heart.org/en/health-topics/heart-valve-problems-and-disease/understanding-your-heart-valve-treatment-options/medications-for-heart-valve-symptoms
  2. American Heart Association. (2022, December 5). Silent Ischemia and Ischemic Heart Disease. Www.heart.org. https://www.heart.org/en/health-topics/heart-attack/about-heart-attacks/silent-ischemia-and-ischemic-heart-disease
  3. Antoine, C., Mantovani, F., Benfari, G., Mankad, S. V., Maalouf, J. F., Michelena, H. I., & Enriquez-Sarano, M. (2018). Pathophysiology of Degenerative Mitral Regurgitation. Circulation: Cardiovascular Imaging, 11(1). https://doi.org/10.1161/circimaging.116.005971
  4. Arora, S., Brown, Z. D., Sivaraj, K., Hendrickson, M. J., Mazzella, A. J., Chang, P. P., Vaduganathan, M., Qamar, A., Gehi, A. K., Pandey, A., & Vavalle, J. P. (2021). The Relationship Between Atrial Fibrillation, Mitral Regurgitation, and Heart Failure Subtype: The ARIC Study. Journal of Cardiac Failure, 28(6). https://doi.org/10.1016/j.cardfail.2021.10.015
  5. Backer, O. D., Wong, I., Taramasso, M., Maisano, F., Franzen, O., & SΓΈndergaard, L. (2021). Transcatheter mitral valve repair: an overview of current and future devices. Open Heart, 8(1), e001564. https://doi.org/10.1136/openhrt-2020-001564
  6. Blake, K. (2023, April 28). What Is a Heart Healthy Diet and Who Should Follow One? Rupa Health. https://www.rupahealth.com/post/what-is-a-heart-healthy-diet-and-who-should-follow-one
  7. CDC. (2024, May 22). Clinical Guidance for Acute Rheumatic Fever. Group a Strep Infection. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/acute-rheumatic-fever.html
  8. Christie, J. (2024, May 17). How to Spot the Top Warning Signs of a Stroke. Rupa Health. https://www.rupahealth.com/post/how-to-spot-the-top-warning-signs-of-a-stroke
  9. Cleveland Clinic. (n.d.). Mitral Valve Disease: Types, Symptoms and Treatment. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/23235-mitral-valve-disease
  10. Cleveland Clinic. (2022a). Mitral Valve: Location, Anatomy and Function. Cleveland Clinic. https://my.clevelandclinic.org/health/body/23244-mitral-valve
  11. Cleveland Clinic. (2022b, January 10). Anticoagulants (Blood Thinners): What They Do, Types and Side Effects. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/22288-anticoagulants
  12. Cleveland Clinic. (2022c, June 3). Marfan Syndrome | Cleveland Clinic. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17209-marfan-syndrome
  13. Cleveland Clinic. (2022d, September 16). Heart Palpitations: Causes, Symptoms, Diagnosis & Treatment. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17084-heart-palpitations
  14. Cleveland Clinic. (2022e, November 11). Dyspnea (Shortness of Breath): Causes, Symptoms & Treatment. Cleveland Clinic. https://my.clevelandclinic.org/health/symptoms/16942-dyspnea
  15. Clinic, M. (n.d.). Congenital mitral valve anomalies - Overview - Mayo Clinic. Www.mayoclinic.org. https://www.mayoclinic.org/diseases-conditions/congenital-mitral-valve-anomalies/cdc-20385802
  16. Cloyd, J. (2023a, March 7). An integrative medicine approach to fatigue. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-fatigue
  17. Cloyd, J. (2023b, April 10). A Functional Medicine Hypertension Protocol. Rupa Health. https://www.rupahealth.com/post/functional-medicine-hypertension-protocol
  18. Cloyd, J. (2023c, July 3). The Role of Physical Activity in Promoting Heart Health. Rupa Health. https://www.rupahealth.com/post/the-role-of-physical-activity-and-exercise-in-promoting-heart-health-including-the-use-of-alternative-exercise-modalities-such-as-tai-chi-and-qigong
  19. Cloyd, J. (2023d, October 9). Rhythms of the Heart: Demystifying Common Types of Heart Arrhythmia. Rupa Health. https://www.rupahealth.com/post/rhythms-of-the-heart-demystifying-common-types-of-heart-arrhythmia
  20. David, T. (2021). How to Decide Between a Bioprosthetic and Mechanical Valve. Canadian Journal of Cardiology, 37(7), 1121–1123. https://doi.org/10.1016/j.cjca.2020.09.011
  21. DePorto, T. (2023, January 10). Timeline: What Happens Inside Your Body When You Quit Smoking? Rupa Health. https://www.rupahealth.com/post/what-happens-to-our-bodies-when-we-quit-smoking-a-timeline
  22. Garcia, A. R., Inarra, A. L., & Martinez de Miguel, S. M. (2023). ECG, an essential tool to guide arrhythmic mitral valve prolapse diagnosis. European Heart Journal - Case Reports. https://doi.org/10.1093/ehjcr/ytad033
  23. Guerrero, M. (2024, April 18). The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery. Clinicaltrials.gov. https://www.clinicaltrials.gov/study/NCT04408430?cond=mitral%20valve&aggFilters=status:act%20rec&rank=5
  24. Hollingshead, C. M., & Brizuela, M. (2023). Antibiotic Prophylaxis In Dental and Oral Surgery Practice. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK587360/
  25. Johns Hopkins Medicine. (2022, January 6). Mitral Valve Repair. Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/mitral-valve-repair
  26. Kim, D., Seo, J., Cho, I., Hong, G., Ha, J., & Chi Young Shim. (2023). Prognostic Implication of Mitral Valve Disease and Its Progression in East Asian Patients With Hypertrophic Cardiomyopathy. Journal of the American Heart Association. Cardiovascular and Cerebrovascular Disease, 12(3). https://doi.org/10.1161/jaha.121.024792
  27. Kluin, J., & Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). (2023, April 12). The Role of Left Atrial Fibrosis in Mitral Valve Repair Surgery (ALIVE Trial). Clinicaltrials.gov. https://www.clinicaltrials.gov/study/NCT05345730?cond=mitral%20valve&aggFilters=status:act%20rec&rank=9
  28. Korovesis, T. G., Koutrolou-Sotiropoulou, P., & Katritsis, D. G. (2022). Arrhythmogenic Mitral Valve Prolapse. Arrhythmia & Electrophysiology Review, 11. https://doi.org/10.15420/aer.2021.28
  29. Lopez-Mattei, J. C., & Shah, D. J. (2013). The Role of Cardiac Magnetic Resonance in Valvular Heart Disease. Methodist DeBakey Cardiovascular Journal, 9(3), 142–148. https://doi.org/10.14797/mdcj-9-3-142
  30. Mayo Clinic. (n.d.). Mitral valve regurgitation - Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/mitral-valve-regurgitation/symptoms-causes/syc-20350178
  31. Mayo Clinic. (2019). Mitral valve repair and mitral valve replacement - Mayo Clinic. Mayoclinic.org. https://www.mayoclinic.org/tests-procedures/mitral-valve-repair-mitral-valve-replacement/about/pac-20384958
  32. Mayo Clinic. (2022a, May 4). Enlarged heart - Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/enlarged-heart/symptoms-causes/syc-20355436
  33. Mayo Clinic. (2022b, May 27). Heart murmurs - symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/heart-murmurs/symptoms-causes/syc-20373171
  34. Mayo Clinic. (2023). Chronic kidney disease. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/chronic-kidney-disease/symptoms-causes/syc-20354521
  35. Mayo Clinic Staff. (2021, September 8). What do ACE inhibitors do for heart health? Mayo Clinic; Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/ace-inhibitors/art-20047480
  36. Mayo Clinic. (n.d.). Chambers and valves of the heart. Mayo Clinic. https://www.mayoclinic.org/chambers-and-valves-of-the-heart/img-20007497
  37. Mount Sinai. (n.d.). Papillary Muscles and the Left Ventricle | Mitral Valve Repair Center. Www.mitralvalverepair.org. https://www.mitralvalverepair.org/papillary-muscles-and-left-ventricle
  38. Miklovic, T., & Sieg, V. C. (2023, May 29). Ehlers Danlos Syndrome. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549814/
  39. Nappi, F., Spadaccio, C., Dreyfus, J., Attias, D., Acar, C., & Bando, K. (2018). Mitral endocarditis: A new management framework. The Journal of Thoracic and Cardiovascular Surgery, 156(4), 1486-1495.e4. https://doi.org/10.1016/j.jtcvs.2018.03.159
  40. National Heart, Lung and Blood Institute. (2022, March 24). Heart Valve Diseases - Causes and Risk Factors | NHLBI, NIH. Www.nhlbi.nih.gov. https://www.nhlbi.nih.gov/health/heart-valve-diseases/causes
  41. Nishimura, R. A., & Carabello, B. A. (2012). Hemodynamics in the Cardiac Catheterization Laboratory of the 21st Century. Circulation, 125(17), 2138–2150. https://doi.org/10.1161/circulationaha.111.060319
  42. Patel, H., Desai, M., Tuzcu, E. M., Griffin, B., & Kapadia, S. (2014). Pulmonary Hypertension in Mitral Regurgitation. Journal of the American Heart Association, 3(4). https://doi.org/10.1161/jaha.113.000748
  43. Platonov, P. G. (2017). Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation? Journal of Geriatric Cardiology: JGC, 14(4), 233–237. https://doi.org/10.11909/j.issn.1671-5411.2017.04.008
  44. Pollock, J. D., & Makaryus, A. N. (2022). Physiology, Cardiac Cycle. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459327/
  45. Rivero-Moreno, Y., Echevarria, S., Vidal-Valderrama, C., Pianetti, L., Cordova-Guilarte, J., Navarro-Gonzalez, J., Acevedo-RodrΓ­guez, J., Dorado-Avila, G., Osorio-Romero, L., Chavez-Campos, C., Acero-AlvarracΓ­n, K., Rivero, Y., Echevarria, S., Vidal-Valderrama, C., Pianetti, L., Guilarte, J. C., Navarro-Gonzalez, J., Acevedo-RodrΓ­guez, J., Avila, G. L. D., & Osorio-Romero, L. (2023). Robotic Surgery: A Comprehensive Review of the Literature and Current Trends. Cureus, 15(7). https://doi.org/10.7759/cureus.42370
  46. Robinson, S., Ring, L., Augustine, D. X., Rekhraj, S., Oxborough, D., Harkness, A., Lancellotti, P., & Rana, B. (2021). The assessment of mitral valve disease: a guideline from the British Society of Echocardiography. Echo Research and Practice, 8(1), G87–G136. https://doi.org/10.1530/ERP-20-0034
  47. Roselli, C., Yu, M., Nauffal, V., Georges, A., Yang, Q., Love, K., Weng, L. C., Delling, F. N., Maurya, S. R., SchrΓΆlkamp, M., Tfelt-Hansen, J., HagΓ¨ge, A., Jeunemaitre, X., Debette, S., Amouyel, P., Guan, W., Muehlschlegel, J. D., Body, S. C., Shah, S., & Samad, Z. (2022). Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse. European Heart Journal, 43(17), 1668–1680. https://doi.org/10.1093/eurheartj/ehac049
  48. SHEA.MICHAEL. (2018). Cardiac Auscultation. Merck Manuals Professional Edition; Merck Manuals. https://www.merckmanuals.com/professional/cardiovascular-disorders/approach-to-the-cardiac-patient/cardiac-auscultation
  49. Sweetnich, J. (2023, May 11). Complementary and Integrative Medicine Treatments for Strep Throat: Herbs, Supplements, and Testing for Reoccurring Strep Throat Infections. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-treatments-for-strep-throat-herbs-supplements-and-testing-for-reoccurring-strep-throat-infections
  50. Varanasi-Diaz, S. (2024, March 18). Are Your Patients on Antihypertensive Drugs?: How Root Cause Medicine Can Complement Their Treatment. Rupa Health. https://www.rupahealth.com/post/are-your-patients-on-antihypertensive-drugs-how-root-cause-medicine-can-complement-their-treatment
  51. Yoshimura, H. (2024, April 12). Nutritional Interventions in Heart Failure Care. Rupa Health. https://www.rupahealth.com/post/nutritional-interventions-in-heart-failure-care
  52. Zia Khan, M., Zahid, S., Khan, M. U., Kichloo, A., Jamal, S., Mannan Khan Minhas, A., Ullah, W., Sattar, Y., & Balla, S. (2021). Redo Surgical Mitral Valve Replacement Versus Transcatheter Mitral Valve in Valve From the National Inpatient Sample. Journal of the American Heart Association. https://doi.org/10.1161/jaha.121.020948
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source